Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and Neck

Recruiting now

Conditions studied: Squamous Cell Carcinoma of Head and Neck

In brief

This study will test the ability of a personalized blood test to determine which head and neck cancer patients will have a recurrence after treatment.

Key facts

Study ID
NCT06744296
Run by
Massachusetts Eye and Ear Infirmary
People needed
75
Starts
2025-02-03
Expected to finish
2029-01-06
Last updated by the study team
2025-05-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.